Panax Ginseng para Age-Related Cognitive Decline
C Evidencia Evidencia limitada de estudios pequeños, pero existen algunas señales positivas.Multiple RCTs with mixed but generally positive results for cognitive function. Evidence is not yet convincing for dementia prevention, but acute cognitive enhancement effects are supported by several trials.
Conclusión
Multiple RCTs with mixed but generally positive results for cognitive function. Evidence is not yet convincing for dementia prevention, but acute cognitive enhancement effects are supported by several trials.
Key Study Findings
Población: None
Población: Alzheimer's disease patients (review)
Población: None
Población: healthy adults
Población: None
Key Statistics
15
Estudios
1500
Participantes
Mixed
Calificación
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Dosificaciones de uso común
- general:
- 200-400 mg/day standardized to 4-7% ginsenosides
Límite superior: Not established; up to 3,000 mg/day used short-term
Dosificaciones estudiadas en la investigación
| Dosificación | Duración | Efecto | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
Mejor momento para tomar: Morning; cycling recommended (8 weeks on, 2 weeks off)
Safety & Side Effects
Efectos secundarios reportados
- ⚠ Insomnia
- ⚠ Headache
- ⚠ Gastrointestinal discomfort
- ⚠ Changes in blood pressure
- ⚠ Rare: hypoglycemia
Interacciones conocidas
- ● Anticoagulants and antiplatelet drugs
- ● Antidiabetic drugs (may lower blood sugar)
- ● MAO inhibitors (may potentiate effects)
- ● Stimulants (additive stimulatory effects)
Ingesta máxima tolerable: Not established; up to 3,000 mg/day used short-term
Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.
Frequently Asked Questions
Does Panax Ginseng help with Age-Related Cognitive Decline?
How much Panax Ginseng should I take for Age-Related Cognitive Decline?
Are there side effects of Panax Ginseng?
How strong is the evidence for Panax Ginseng and Age-Related Cognitive Decline?
Related Evidence
Otros ingredientes para Age-Related Cognitive Decline
Panax Ginseng para otras condiciones
References
- [1] Rarchita Sharma et al.. Nutr Neurosci. 2025. Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection. doi:10.1080/1028415X.2025.2469170 PubMed
- [2] Jingyi Li et al.. Psychopharmacology (Berl). 2025. Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice. doi:10.1007/s00213-025-06828-5 PubMed
- [3] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
- [4] John E Lewis et al.. J Clin Transl Res. 2021. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. PubMed
- [5] Cindy Crawford et al.. J Altern Complement Med. 2021. Dietary Supplement Ingredients for Optimizing Cognitive Performance Among Healthy Adults: A Systematic Review. doi:10.1089/acm.2021.0135 PubMed
- [6] Andrea Brioschi Guevara et al.. Alzheimers Res Ther. 2021. Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6. doi:10.1186/s13195-021-00844-1 PubMed
Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.